Conn. Jumps Into Zyprexa Fray With Lawsuit
Echoing allegations that Eli Lilly already faces in a massive multidistrict litigation in the Eastern District of New York, Connecticut alleges that Eli Lilly first overcharged for the drug and then marketed it through a fraudulent campaign that concealed its possible link to diabetes.
The lawsuit also alleges that the company engaged in racketeering with medical marketing firms and doctors in...
Already a subscriber? Click here to login